Anzeige
Mehr »
Dienstag, 23.12.2025 - Börsentäglich über 12.000 News
Breaking News: Drohnenabwehr aus Israel für die NATO?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PH0N | ISIN: CA2524423068 | Ticker-Symbol: 4D4A
Frankfurt
23.12.25 | 08:06
0,204 Euro
+9,68 % +0,018
1-Jahres-Chart
DIAGNOS INC Chart 1 Jahr
5-Tage-Chart
DIAGNOS INC 5-Tage-Chart

Aktuelle News zur DIAGNOS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrDiagnos Inc (3): Diagnos 13,337,262-share private placement1
MiDiagnos Inc (3): Diagnos appoints Ben Ayed as chief AI scientist1
16.12.DIAGNOS Inc.: DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare126BROSSARD, Quebec, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in applying techniques in Artificial Intelligence...
► Artikel lesen
11.12.Diagnos Inc (3): Diagnos 4,627,931 warrants extended1
DIAGNOS Aktie jetzt für 0€ handeln
09.12.DIAGNOS Inc.: Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital1
26.11.Diagnos Inc (3): Diagnos increases financing to $3.65-million1
25.11.DIAGNOS Inc.: Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital3
13.11.DIAGNOS Inc.: DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 20251
10.11.DIAGNOS Inc.: DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital2
30.10.Diagnos Inc (3): Diagnos appoints Couillard as chairman5
30.10.DIAGNOS Inc.: DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors154BROSSARD, Quebec, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues...
► Artikel lesen
27.10.Diagnos Inc (3): Diagnos appoints Charlebois to advisory board1
27.10.DIAGNOS Inc.: DIAGNOS Welcomes Dr. Pierre-Luc Charlebois to its Advisory Board1
23.10.Diagnos Inc (3): Diagnos to extend 1.12 million warrants to 20262
22.10.DIAGNOS Inc.: DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 20251
15.10.Centurion One Capital Corp.: DIAGNOS to Present at the Centurion One Capital 3rd Annual Bahamas Summit341Brossard, Quebec--(Newsfile Corp. - October 15, 2025) - Diagnos Inc. (TSXV: ADK) (OTCQB: DGNOF) (FSE: 4D4A) ("DIAGNOS" or the "Corporation"), a pioneer in early detection of critical health issues...
► Artikel lesen
09.10.Diagnos Inc (3): Diagnos passes annual MDSAP audit1
26.09.Diagnos Inc (3): Diagnos shareholders elect four directors at AGM4
25.09.DIAGNOS Inc.: DIAGNOS Announces Voting Results of Meeting of Shareholders91BROSSARD, Quebec, Sept. 25, 2025 (GLOBE NEWSWIRE) -- DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues...
► Artikel lesen
11.09.Diagnos Inc (3): Diagnos $100,000 debenture private placement3
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1